For research use only. Not for therapeutic Use.
EGR240 is a branched-chain amino acid aminotransferase 1 (BCAT1) inhibitor. EGR240 can be used for the research of cancer, rheumatoid arthritis, and bone disease[1].
| Catalog Number | I042517 |
| CAS Number | 1415683-79-2 |
| Synonyms | sodium;4-methyl-5-oxohexanoate |
| Molecular Formula | C7H11NaO3 |
| Purity | ≥95% |
| InChI | InChI=1S/C7H12O3.Na/c1-5(6(2)8)3-4-7(9)10;/h5H,3-4H2,1-2H3,(H,9,10);/q;+1/p-1 |
| InChIKey | QEQCTLAIARYMND-UHFFFAOYSA-M |
| SMILES | CC(CCC(=O)[O-])C(=O)C.[Na+] |
| Reference | [1]. Papathanassiu, et al. Methods for treatment of cancer, inflammatory autoimmune disorders and bone diseases using branched-chain amino acid aminotransferase-1 (BCAT1) inhibitors. Patent. WO2012173987. |
